OB-0002

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameOB-0002

Drug Alias NameSrc tyrosine kinase inhibitor (Oribase)ORB-0002OB-0002

ClassificationSmall molecules

Mechanisms of ActionAnticancer protein kinase inhibitorsTyrosine-protein kinase SRC inhibitors

TargetsTyrosine-protein kinase SRC

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesOriBase Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesOriBase Pharma

Active IndicationsN/A

Inactive IndicationsSolid tumours

ATC CodeN/A